{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"8","upperLimit":"16","value":"10"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"44"}],"units":"Participants"}],"description":"Neutrophil engraftment is defined as the first of three consecutive days with absolute neutrophil count \\>500/mm3. Platelet engraftment is defined as the first of 3 consecutive days of platelets \\> 20,000/mm3 without platelet transfusion in the prior 7 days.","dispersionType":"Full Range","groups":[{"description":"All patients who receive transplant in the phase 1+2 of the study","id":"OG000","title":"Patients Undergoing Transplantation"}],"paramType":"MEDIAN","populationDescription":"All patients","reportingStatus":"POSTED","timeFrame":"Up to 1 month.","title":"Median Time for Neutrophil and Platelet Engraftment.","type":"PRIMARY","unitOfMeasure":"days"}